Individualized treatment of osteoporosis

被引：0

作者：

Harbeck, B. ^{[1
]}

Lehnert, H. ^{[2
]}

机构：

[1] Univ Lubeck, Med Klin 1, Univ Klinikum Schleswig Holstein, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany

[2] Univ Lubeck, Prasidium, Lubeck, Germany

来源：

INTERNIST | 2016年 / 57卷 / 07期

关键词：

Osteoporosis; drug therapy; Age factors; Comorbidity; Risk assessment; Fracture prophylaxis; BONE-MINERAL DENSITY; VERTEBRAL FRACTURE RISK; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; BISPHOSPHONATES; DENOSUMAB; TERIPARATIDE; EFFICACY; ALENDRONATE; PREVENTION;

D O I：

10.1007/s00108-016-0074-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Osteoporosis is the most common clinical disorder of bone metabolism. Treatment decisions should be made on an individual basis, taking into consideration the relative benefits and risks in different patient populations. Drug selection should be based on the form (primary/secondary) and severity of osteoporosis, age, sex, the specific contraindications and precautions for using the various available medications, and existing comorbidities.

引用

页码：638 / +

页数：7

共 50 条

[1] Medical treatment of osteoporosis
Palacios, S.
CLIMACTERIC, 2022, 25 (01) : 43 - 49
[2] Osteoporosis treatment. Systematic review
Vielma-Guevara, Jose Ramon
AVANCES EN BIOMEDICINA, 2023, 12 (01) : 6 - 20
[3] Pharmacological treatment of osteoporosis: 2022 update
Jeon, Yunkyung
Kim, In-Joo
JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (04): : 241 - 248
[4] Polypharmacy in Osteoporosis Treatment
McConnell, Megan
Shieh, Albert
CLINICS IN GERIATRIC MEDICINE, 2022, 38 (04) : 715 - 726
[5] Denosumab for the treatment of osteoporosis
Zaheer, Sarah
LeBoff, Meryl
Lewiecki, Michael
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (03) : 461 - 470
[6] Current approaches to osteoporosis treatment
Lim, Sian Yik
Bolster, Marcy B.
CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (03) : 216 - 224
[7] A narrative review of the pharmaceutical management of osteoporosis
Patel, Devon
Gorrell, Courtney
Norris, Jordan
Liu, Jiayong
ANNALS OF JOINT, 2023, 8
[8] Indications to teriparatide treatment in patients with osteoporosis
Rizzoli, Rene
Kraenzlin, Marius
Krieg, Marc-Antoine
Mellinghoff, Hans-Ulrich
Lamy, Olivier
Lippuner, Kurt
SWISS MEDICAL WEEKLY, 2011, 141
[9] Treatment options for glucocorticoid-induced osteoporosis
Chiodini, Iacopo
Merlotti, Daniela
Falchetti, Alberto
Gennari, Luigi
EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (06) : 721 - 732
[10] Osteoporosis in older persons: current pharmacotherapy and future directions
Duque, Gustavo
EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1949 - 1958

← 1 2 3 4 5 →